Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022.

Matthew P Smeltzer Olawale A Akinbobola Meredith A Ray Carrie Fehnel Andrea Saulsberry Kourtney R Dortch Kelly Pimenta Anberitha T Matthews Raymond U Osarogiagbon

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)

The association of institutional, pathologist, and surgeon characteristics with differences in testing demonstrate the need for more standardization in testing processes.

Keyphrases

epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
risk factors
robot assisted